Drug Companies To Federal Circuit: Suboxone Film Patents Are Invalid
WASHINGTON, D.C. — In an appellant brief filed April 23, three generic drug makers tell the Federal Circuit U.S. Court of Appeals that the asserted claims of a patent covering a...To view the full article, register now.
Already a subscriber? Click here to view full article